Glassman AR, Wells JA 3rd, Josic K, Maguire MG, et al. Five-Year Outcomes after Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T Extension Study). Ophthalmology 2020 Mar 29. pii: S0161-6420(20)30304.
PMID: 32402554